| No | Title | Writer | Date | Hit |
|---|---|---|---|---|
| 1 | AbBio Co.,Ltd. has entered into Letter of Commitment with Noile-Immune Biotech Inc. and National Cancer Center for the development and commercialization of FCAR-CD20 CAR-T and plans to broaden sCAR-T applications. | AbBio | 2025-06-04 | 209 |
